Search results
They had the same name. The same childhood cancer. They lost touch – then reunited.
USA Today· 4 days agoSeveral decades ago, two New Orleans children developed the same disease: acute lymphoblastic ...
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Zacks via Yahoo Finance· 19 hours agoChemotherapy drug Rylaze/Enrylaze recorded sales of $102.8 million in the quarter, up 20% year over...
BMO Capital Markets Lowers Incyte (NASDAQ:INCY) Price Target to $52.00
ETF DAILY NEWS· 5 hours agoIncyte (NASDAQ:INCY – Get Free Report) had its price target cut by BMO Capital Markets from $56.00 to $52.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently ...
Hyundai Hope on Wheels surpasses $250 million raised for pediatric cancer; survivor shares journey
ABC 7 Chicago· 2 days agoThe continued fight to end childhood cancer is getting a boost. Hyundai's Hope on Wheels has been...
Unraveling the roles of non-coding DNA explains childhood cancer's resistance to chemotherapy
Medical Xpress· 2 days agoThe findings are published in Nature Communications. Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. The researchers ...
After Childhood Cancer Diagnosis, Donor Bone Marrow from Little Sister Sends it into Remission
GoodNewsNetwork· 3 days agoA young girl in the English city of Sheffield has seen her rare blood cancer go into complete...
StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS)
ETF DAILY NEWS· 3 days agoStockNews.com initiated coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a report published on Saturday. The firm issued a sell rating on the biotechnology company’s stock. Cellectis ...
9-year-old cancer survivor surprised with first pitch at Buffalo Bisons game
WKBW-TV Buffalo· 6 days agoOn Friday night, 9-year-old Mya Culley walked into Sahlen field thinking she would enjoy the evening...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 2 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 2 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the ...
